Age at onset of puberty following high-dose central nervous system radiation therapy

S. E. Oberfield, D. Soranno, A. Nirenberg, G. Heller, J. C. Allen, R. David, L. S. Levine and C. A. Sklar
Department of Pediatrics, New York University Medical Center, New York, USA.

OBJECTIVE: To determine if a relationship exists between age at irradiation, sex of the patient, and age at onset of puberty and pubarche in children treated with high-dose radiation to the central nervous system. DESIGN: Case series. SETTING: Tertiary care institutional practices and clinics. PATIENTS: Thirty-six children treated with high-dose irradiation (hypothalamic pituitary dose, 30-72 Gy) by conventional (n = 29) or hyperfractionated (n = 7) schedules. Girls were treated before age 8 years and boys before age 9 years. Twenty-six of the 36 children also received chemotherapy. All tumors were distant from the hypothalamic-pituitary region. MAIN OUTCOME MEASURE: Age at onset of puberty and pubarche. RESULTS: In girls, the median age at onset of puberty was 9.3 years vs 10.9 years for controls (P < .01); pubarche occurred at 9.4 years vs 11.2 years for controls (P < .01). In boys, the median age at onset of puberty--genital II--was 11.0 years vs 11.5 years for controls (P = .30); pubarche occurred at a median age of 10.5 years vs 12 years for controls (P = .25). A censored-data normal linear regression model was used to account for children (n = 6) who had not reached puberty. Age at diagnosis (P < .01) and sex (P = .01) were significant predictors of age at onset of puberty. Body mass index SD score (z score) was inversely related to age at onset of puberty (r = -0.77) and was greater at onset of puberty in girls than in boys. CONCLUSION: In children who have received high-dose cranial radiation therapy, a significant positive correlation exists between age at diagnosis and age at onset of puberty in boys and girls.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Longitudinal Changes in Obesity and Body Mass Index Among Adult Survivors of Childhood Acute Lymphoblastic Leukemia: A Report From the Childhood Cancer Survivor Study
Garmey et al.
JCO 2008;26:4639-4645.
ABSTRACT | FULL TEXT  

Long-Term Health Status Among Survivors of Childhood Cancer: Does Sex Matter?
Armstrong et al.
JCO 2007;25:4477-4489.
ABSTRACT | FULL TEXT  

Growth Hormone Therapy in Children after Cranial/Craniospinal Radiation Therapy: Sexually Dimorphic Outcomes
Lerner et al.
J. Clin. Endocrinol. Metab. 2004;89:6100-6104.
ABSTRACT | FULL TEXT  

Factors That Affect Final Height and Change in Height Standard Deviation Scores in Survivors of Childhood Cancer Treated with Growth Hormone: A Report from the Childhood Cancer Survivor Study
Brownstein et al.
J. Clin. Endocrinol. Metab. 2004;89:4422-4427.
ABSTRACT | FULL TEXT  

Final Height and Body Mass Index among Adult Survivors of Childhood Brain Cancer: Childhood Cancer Survivor Study
Gurney et al.
J. Clin. Endocrinol. Metab. 2003;88:4731-4739.
ABSTRACT | FULL TEXT  

Improvements in Final Height Over 25 Years in Growth Hormone (GH)-Deficient Childhood Survivors of Brain Tumors Receiving GH Replacement
Gleeson et al.
J. Clin. Endocrinol. Metab. 2003;88:3682-3689.
ABSTRACT | FULL TEXT  

Obesity in Adult Survivors of Childhood Acute Lymphoblastic Leukemia: A Report from the Childhood Cancer Survivor Study
Oeffinger et al.
JCO 2003;21:1359-1365.
ABSTRACT | FULL TEXT  

Long-Term Survivors of Childhood Cancer: The Late Effects of Therapy
Schwartz
The Oncologist 1999;4:45-54.
ABSTRACT | FULL TEXT